Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Strangling tumours in bid to halt cancer

23.09.2005


It may be possible to halt cancer in its tracks by blocking a gene critical to building tumour supply lines, according to new research carried out at the University of Queensland, Australia.



Most tumours need a blood supply to grow.

Researchers at the Institute for Molecular Bioscience have found that when new blood vessels form – in developing embryos and in tumours – a gene, known as Sox18, switches on for just 48 hours.


“In adult mice, we have found that interfering with this gene reduces tumour growth by up to 80 percent,” says postdoctoral scientist Dr Neville Young.

Neville is one of thirteen early-career researchers who have presented their work to the public and media for the first time as part of the national program Fresh Science. One of the Fresh Scientists will win a trip to the UK courtesy of British Council to present their work to the Royal Institution.

“A surprisingly large number of people carry microscopic tumours inside their bodies but these cells never develop into disease.

“One of the reasons these cancerous cells do not rage out of control is that they never establish a blood supply to feed them. Those unlucky enough to develop malignant tumours often do so when cancerous cells co-opt the body’s own blood supply.”

Sox18 has an important role to play in helping specialised cells travel to the right position and then form the tubes needed for blood flow.

Dr Young says that targeting blood vessels was not a new concept in the fight against cancer, but that one of the big problems was the side effects of current treatments.

“The novel thing about targeting Sox18 is that it is only turned on in new blood vessels feeding the growing tumour,” he says. “It does not seem to affect any other blood vessels in the body. By attacking only Sox18 we might be able to stop these new vessels forming while leaving the rest of the blood supply alone.”

The next step is to test whether researchers can manufacture a drug for humans that can mimic the observed effects in mice. They also need to design a delivery system to get the drug to the growing blood vessel cells to switch Sox18 off.

The early stages of this research are already underway with preliminary results expected within two years. This is dependent on ongoing funding for this research.

Niall Byrne | alfa
Further information:
http://www.scienceinpublic.com/sciencenow/2005/nevilleyoung/nevilleyoung.htm

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>